Position in PRAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$80,646,556
+$7,208,503 QoQ
Shares Held
240,887
+5.7% QoQ
Ownership
0.863%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 308 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. PRAX ranks #21 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in PRAX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,646,556 | 240,887 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $73,438,053 | 227,934 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $56,673,783 | 192,284 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $8,922,709 | 168,353 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $8,986,588 | 213,712 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $6,255,478 | 165,183 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $12,897,724 | 167,590 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $8,761,441 | 152,267 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,988,132 | 48,069 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,664,563 | 27,279 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $431,429 | 19,364 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $506,174 | 296,009 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $138,572 | 120,498 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $328,618 | 406,203 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $837,452 | 351,871 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $841,247 | 370,594 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $910,090 | 371,466 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,242,806 | 317,611 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,192,102 | 314,320 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,514,161 | 298,224 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,079,838 | 223,186 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,953,803 | 120,690 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,005,420 | 127,325 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||